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Abbreviations 
AAD: Allergic airways disease 
APC: Antigen presenting cell 
BAL: Broncho-alveolar lavage 
Dhh: Desert hedgehog 
GFP: green fluorescent protein 
Gli: Glioma-associated oncogene 
GliA: transcriptional activator Gli 
GliR: transcriptional repressor Gli 
HDM: House dust mite 
Hh: Hedgehog 
Hhip: Hedgehog interacting protein 
Ihh: Indian hedgehog 
KO: knockout 
LN: Lymph node 
Ptch: Patched 
Shh: Sonic hedgehog 
Smo: Smoothened 
Th2: T-helper 2 
Wk: week/s 
WT: wild type 
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Abstract 
The pathophysiology of allergic asthma is driven by T-helper 2 (Th2) immune responses 
following aeroallergen inhalation.  The mechanisms that initiate, potentiate and regulate 
airways allergy are incompletely characterized.  We have previously shown that Hedgehog 
(Hh) signaling to T-cells, via downstream Gli transcription factors, enhances T-cell 
conversion to a Th2 phenotype.  Here, we show for the first time that Gli-dependent 
transcription is activated in T-cells in vivo during murine allergic airways disease (AAD) a 
model for the immunopathology of asthma; and that genetic repression of Gli signaling in T-
cells decreases the differentiation and/or recruitment of Th2 cells to the lung.  We report that 
T-cells are not the only cells capable of expressing activated Gli during AAD.  A substantial 
proportion of eosinophils and lung epithelial cells, both central mediators of the 
immunopathology of asthma, are also able to undergo Hh/Gli signaling.  Finally, we show 
that Shh increases Il4 expression in eosinophils.  We therefore propose that Hh signaling 
during AAD is complex, involving multiple cell types, signaling in an auto- or paracrine 
fashion.  Improved understanding of the role of this major morphogenetic pathway in asthma 
may give rise to new drug targets for this chronic condition.               
4 
 
Introduction 
Asthma is a complex, heterogeneous respiratory disease characterized by airway 
inflammation, hyperresponsiveness, obstruction and remodeling.  For many, asthma is a 
chronic, life-long condition controlled by inhaled corticosteroids, leukotriene antagonists, and 
short or long-acting bronchodilators.  Approximately three people a day die as a result of 
asthma in the UK alone (Asthma UK Data Portal & Office for National Statistics).  Asthma 
can be sub-divided into a series of variable phenotypes, categorized by the prominent cellular 
infiltrates and pathophysiology observed in the airway [1].  The majority of asthma is thought 
to be triggered by allergens (allergic asthma) and is characterized by eosinophilia and T-
helper type 2 (Th2) immune responses.  Allergic conditions are linked to epithelial barrier 
dysfunction, which potentiates immune responses to allergens, although the mechanisms 
behind this are not clear [2]. 
Allergic asthma results from misguided immune reactivity to aeroallergen, the most common 
of which are derived from house dust mite species (HDM) [3].  Sensitization is complex and 
is dependent on a series of genetic and environmental factors including extent of aeroallergen 
exposure, predisposition to atopy, composition of personal microbiota, exposure to pollutants 
and time spent indoors in early life [4].  Aeroallergens are ingested by mucosal antigen 
presenting cells (APC) and presented to T-cells in local lymph nodes (LN).  T-cell activation 
and conversion to a Th2 phenotype triggers the production of IgE, subsequent activation of 
mast cells, eosinophils and the production of inflammatory mediators.  Persistent allergen 
exposure, sustained immune infiltration and chronic inflammation result in excessive mucus 
production, smooth muscle contraction, airway remodeling and hyperresponsiveness, leading 
to the symptoms of asthma.   
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The mechanisms driving Th2 conversion and persistence in response to inhaled allergens are 
incompletely characterized.  The heterogeneity of asthma phenotypes, disease course and 
treatment response implies that there are many factors that synergize to determine phenotype 
and increase overall risk of disease and/or treatment failure.  It is therefore important to 
dissect the molecular mechanisms that contribute to the induction and persistence of Th2 
immune pathology.  
We have previously shown that Hedgehog (Hh) signaling to T-cells potentiates 
differentiation of naïve T-cells to a Th2 phenotype, and that Sonic Hedgehog (Shh) ligand is 
upregulated in the airway of mice with allergic airways disease, a murine model of asthma 
pathophysiology [5].  This work indicates that Shh is one such factor that can contribute to 
Th2-mediated responses.  The relationship between Shh signaling and allergic asthma has not 
been explored in detail to date. 
Hh proteins are inter-cellular signaling molecules that are vital for patterning during 
embryogenesis but also play a number of roles postnatally in tissue homeostasis [6].  There 
are three mammalian Hh proteins: Sonic Hh (Shh), Desert Hh (Dhh) and Indian Hh (Ihh), all 
of which share a common signaling pathway.  Upon ligand binding to the Hh receptor Ptch, 
signal transduction is initiated by de-repression of Smo, which triggers an intracellular 
signaling cascade culminating in the activation of Gli transcription factors.  Gli-dependent 
transcription of target genes is driven by the abundance of activated Gli (GliA) relative to 
transcriptional repressor Gli (GliR) in the cell.  Gli1 acts as an activator of transcription, Gli2 
as an activator and repressor, whereas Gli3 is predominantly a transcriptional repressor [7].  
Target genes of Gli are wide-ranging and cell-context dependent.  We have shown that in 
mature CD4+ T-cells, Gli target genes include Hh signaling molecules: Ptch1 [8], Smo [5], 
Th2-modulators: Il4, Il1rl1 [5], and genes linked to allergic disease: Tgfb3 [9], Igf1r [10] and 
Csf2 [11].   
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Several genes related to the Hh signaling pathway have been linked to asthma.  Large 
genome-wide association studies (GWAS) have implicated HHIP [12], PTCHD1 [13] and 
PTCHD3 [14] in poorer asthmatic lung function.  Gene expression analyses comparing Th2-
high and Th2-low asthma phenotypes found differences in expression of Dhh and Disp1 
between groups [15].  These findings have been predominantly discussed in the context of 
developmental biology, the authors suggesting that the Hh pathway may be linked to lung 
function as a consequence of its role in lung branching morphogenesis.   
We have shown that Hh signaling via Gli-dependent transcription potentiates the conversion 
of naïve T-cells to Th2 effectors by upregulation of Th2-related genes including the key 
cytokine IL-4 [5].  We therefore propose that the linkage between Hh signaling and asthma 
may be due to the influence of Hh on Th2 immune responses in addition to any structure-
function effects driven by differences in morphogen signaling during lung development and 
postnatally in lung tissue homeostasis.  Here, we investigate the relationship between Hh/Gli 
signaling and allergic immune responses in vivo using murine models of asthma pathology.  
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Materials and methods 
Mice, tissues and cells 
Lck-Gli2ΔC2 (C2, Gli2R [8]), GFP-Gli reporter mice (Gli binding site-GFP transgenic, GBS-
GFP Tg [16]) and littermate/age-matched controls, all C57BL/6 background, C57BL/6 and 
BALB/c WT mice were bred and maintained at UCL under UK Home Office regulations.  
Allergic airways disease (AAD) was induced as described [5].  HDM allergen was given 
three times per week for the number of weeks stated.  BAL, lung lobes and draining LN were 
harvested.  Lung tissue was cryopreserved for sectioning or homogenization or minced and 
digested with 1.5mg/ml Liberase (Roche) and 0.5mg/ml DNAse (Roche), subject to 
erythrocyte lysis and prepared for flow cytometry, or subject to lysis for RNA extraction.  To 
obtain SiglecF+ cells (eosinophils), cells were purified from pooled BALB/c lung and spleen 
leukocytes by Streptavidin-based magnetic bead positive selection (eBioscience) using anti-
SiglecF-biotin (Miltenyi).  Cells were then cultured at 2.5x105/ml in AIMV media 
(LifeTechnologies) for 24h in the presence or absence of 500ng/ml recombinant Shh (R&D 
Systems) prior to lysis for RNA extraction.  
Flow cytometry and cell sorting 
Samples were stained using antibodies from eBioscience (UK), acquired on a C6 Accuri flow 
cytometer (BD) and analyzed using FlowJo v10 (Tree Star).  For cell sorting, samples were 
acquired on a MoFlo XDP or FACSDiva (Beckman Coulter) and  defined as follows:  
Epithelium: CD45-Epcam+; Endothelium: CD45-Epcam-CD31+; Eosinophils: 
SiglecF+CD11b+; neutrophils: CD11b+Ly6G(IA8)hi; Alveolar macrophages: 
CD11bloCD11c+; CD4+ T-cells: CD4+CD11c-.     
qPCR 
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qPCR was performed in triplicate for at least two independent experiments using Quantitect 
primers (Qiagen) on a Rotor-Gene thermal cycler (Qiagen) or a Biorad iCycler.  Data were 
normalized to Hprt expression and are represented as relative mean expression±SD of 
independent experiments, the number of data points indicating the number of mice/samples 
analyzed. 
Immunofluorescence 
Immunofluorescence was performed on fresh frozen acetone fixed 5µm sections of OCT-
embedded lung tissue.  All antibodies were from eBioscience unless otherwise stated. To 
detect Shh: goat anti-Shh clone N19 (Santa Cruz), followed by donkey anti-goat biotin 
(Alpha Diagnostic) and streptavidin-Alexa Fluor 555 or anti-biotin Alexa Fluor 488; E-
Cadherin: anti-E-cadherin followed by anti-rat IgG1 PE; SiglecF: anti-mouse SiglecF and 
anti-rat IgG2a eFluor570; CD16: anti-mouse CD16/32 followed by anti-rat IgG2a eFluor570; 
CD45: anti-mouse CD45.2-FITC. CD31: anti-mouse CD31-APC.  Data were captured on an 
Olympus BX63 epifluorescent microscope or Zeiss LSM 710 confocal microscope and 
analyzed using cellSens (Olympus) and Image J (NIH) software.  Magnifications are given as 
power of microscope of objective, where multiple magnifications are used in one figure scale 
bars are also included. 
Lung histology 
Lung lobes were formalin-fixed paraffin embedded (FFPE) samples.  5µm sections were 
subjected to Periodic Acid Schiff staining with hematoxylin counterstaining.  Sections were 
assessed by a blinded observer and scored for cellular infiltration and PAS+ mucus 
production.  Scores denote infiltration/mucus production as 0-1: minimal; 1-2: moderate; 2-3: 
severe. 
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Data analysis 
Statistical analyses were performed using Microsoft Excel or Prism 4 (Graph Pad). Two-
tailed unpaired Student's t-tests were used to assess statistical significance, which was 
accepted at p<0.05. All data are represented as mean±SEM, with the exception of qPCR data, 
which are displayed as stated above.  
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Results and Discussion 
Shh expression increases in lung during AAD induction by allergen administration 
We have previously shown that Shh signals to T-cells to favor a Th2 immune response and 
that Shh protein is increased in the lung tissue of mice after three weeks of allergen dosing 
[5].  To further understand when and where Hh ligand is expressed during AAD induction, 
we examined expression of Shh in lung during a time course of allergen administration.  
BALB/c mice were given three doses of HDM allergen per week for 0, 1, 2, 3 or 5 weeks.  A 
progressive induction of a classical Th2 immune response was observed including the 
appearance of CD4+T1ST2+ (Th2) cells in BAL (Fig. S1A), lung (Fig. S1B) and 
eosinophilia (Fig. S1C).  Concurrently, we observed a progressive increase in Shh mRNA 
(Fig. S1D) and protein (Fig. S1E) in lung tissue.  Shh co-localized with E-cadherin+ airway 
epithelia (Fig. S1F), supporting our published observations.  Further, as early as one week 
into the AAD time course we also observed Shh expression around pulmonary vessels (v) and 
in areas of cellular infiltration (i) around bronchi/bronchioles (Fig. S1F).  Interestingly, Shh 
co-localised with a subset of peribronchiolar CD45+ cells (Fig. S1G), indicating that in 
addition to epithelia, cells of hematopoietic origin express Shh during AAD.  We therefore 
show that there are several potential cellular sources of Shh, some of which are recruited to 
the disease site during AAD.         
Lymphocytes respond to Gli-activating signals in vivo during AAD 
To directly test our hypothesis that lymphocytes receive Hh/Gli-activating signals in vivo 
during AAD [5], we performed a time course allergen dosing experiment on GFP-Gli reporter 
mice [16] and WT (non-GFP) littermates.  GFP-Gli+ mice are engineered to express GFP in 
cells that have received an activating signal upstream of the Gli transcription factors.  GFP 
expression inside cells reflects the presence of GliA and therefore activation of Gli-dependent 
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transcription.  To ensure that the reporter did not have any background effect on our 
experiments, we compared AAD immune parameters in GFP-Gli+ and GFP-Gli- littermates.  
Across a five week AAD time course there were no differences in immune cell recruitment 
between the two genotypes, indicating that the presence of the reporter construct does not 
itself have any influence on AAD progression (Fig. 1A).   
Using GFP-Gli+ mice, we then examined expression of GFP in lymphocytes and CD4+ cells 
during an AAD time-course.  GFP+CD4+ cells were observed in draining LN after only one 
week of allergen dosing with a further increase at three weeks (Fig. 1B, C).  GFP+ cells were 
also evident in BAL (Fig. 1D, E) and lung (Fig. 1F, G), indicating that lymphocytes undergo 
Gli-dependent transcription during AAD.  Upon allergen inhalation, the number of 
GFP+CD4+ cells increased in LN and particularly in BAL, which represents a major site of 
immune reactivity at the interface between the epithelium and the airspaces.  These data 
suggest that there is a subset of T-cells in vivo that are able to respond to Hh or other Gli-
activating signals and that these cells increase in number during AAD.  Our previous work 
suggested that such cells would potentiate a Th2 response [5].  We therefore hypothesized 
that repression of Gli activity in T-cells would limit a Th2 response in vivo, and dampen 
allergic pathology.   
Repression of Gli activity in T-cells impairs the recruitment of CD4+ and Th2 cells during 
AAD 
To test the effect of repressing Gli activity in T-cells on AAD, we induced disease in 
transgenic mice that overexpress the repressor form of Gli2 (Gli2R) under the control of the 
Lck promoter (C2, Lck-Gli2R).  Gli-dependent transcription is therefore repressed in these 
mice in T-cells only:  C2 T-cells do not efficiently upregulate Gli target genes compared to 
WT T-cells upon receipt of a Hh signal [8].  C2 and WT littermates were given PBS or HDM 
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allergen for three weeks and the T-cell phenotype was examined.  As predicted, there were 
significantly fewer CD4+T1ST2+ Th2 cells recruited to the lungs (Fig. 2A) and LN (Fig. 2B) 
of C2 compared to WT mice during AAD.  This indicates that there is a specific effect of 
Gli2 repression on the differentiation and/or recruitment of CD4+ Th2 cells during AAD.  It 
is particularly noteworthy that C2 tissues contain fewer CD4+T1ST2+ cells during AAD 
because these transgenic mice show enhanced selection of CD4+ single positive cells in the 
thymus, and an increased proportion and enhanced signaling/activation/proliferation potential 
of CD4+ cells in peripheral lymphoid tissues [8, 17]. 
Interestingly, we noted a significant decrease in the presence of neutrophils in the lung and 
BAL of C2 mice after allergen administration (Fig 2C).  This implies that the repression of 
Gli activity in T-cells has a secondary effect on the recruitment, activation or differentiation 
of neutrophils in response to HDM inhalation.  There are comparable neutrophil numbers in 
lung and BAL in the PBS treated C2 and WT groups (Fig 2C), suggesting that neutrophil 
development is not impaired in C2 mice.  It therefore seems plausible that the presence of 
GliR in T-cells alters the production of a factor that controls neutrophil proliferation, 
mobilization or chemotaxis to the lung in response to inflammation/danger.  Of interest, C2 
CD4+ T-cells express lower levels of Csf2 transcript than WT [5] – this gene encodes GM-
CSF, a key cytokine for neutrophil recruitment and activation [18].     
However, when we measured AAD pathology in the lungs of C2 and WT mice we noted no 
significant differences between the two genotypes.  Despite the decrease in the number of 
Th2 cells, eosinophilia was not significantly different (Fig. 2D), Periodic Acid Schiff staining 
revealed comparable mucus production, and histological examination of lung infiltration 
suggested that overall, AAD pathology was not diminished in the lungs (Fig. 2E, F).  Th2-
related cytokines in whole lung homogenates were equivalently induced by HDM treatment 
in WT and C2 groups (Fig. 2G), despite the fact that T1ST2+ population was reduced in C2 
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mice.  This suggests that other cells are responsible for the majority of IL4, IL5 and IL13 in 
lung.  Indeed, Th2 cells are not the only source of these cytokines: among other cells, 
eosinophils, recruited in large numbers during AAD, also produce IL-4, IL-5 and IL-13 [19].   
We therefore considered the possibility that there are other, as yet uncharacterized cells in the 
lung that are able to respond to Shh during AAD and influence Th2 responses.   
Innate immune cells and lung epithelium respond to Gli-activating signals in vivo  
To assess whether other cells involved in AAD are able to respond to Hh/Gli signaling, we 
screened for GFP expression and thus GliA during an AAD time course in GFP-Gli+ reporter 
mice.  We examined sections of lung lobes to determine the location of GFP+ cells.  We 
found no GFP expression in GFP-Gli- littermate lung samples (Fig. 3A), but GFP was highly 
expressed around lung structures including bronchial/bronchiolar and alveolar epithelium and 
diffusely throughout other areas of the lung during AAD in GFP-Gli+ lungs (Fig. 3B).  We 
noted variable and graded expression of GFP throughout the tissue, implying that some cells 
expressed higher levels of Gli than others.  This is consistent with graded signaling as would 
be expected with a morphogen and is detectable using this reporter, which has been 
previously used to model the dynamics of morphogen signaling in neural development [16].  
It is currently unknown to what extent morphogen gradients function in adult tissue. Hh 
signaling in adult lung has promoted pro-mitogenic [20, 21] and anti-proliferative [22] effects 
in models of acute lung injury.  These conflicting results could be due to differences in 
experimental models or may reflect functional differences in morphogen gradients in tissues.   
Co-immunofluorescence analyses showed that GFP signal was strongest in E-cadherin+ 
bronchial cells and in peri-bronchial cells following 3wk allergen inhalation, particularly at 
the air-interface (Fig. 3C).  Weaker GFP signal (seen on merged images as pink-yellow, 
depending on the strength of the GFP signal) also co-localized with a subset of peri-bronchial 
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SiglecFhi cells, possibly those eosinophils about to egress into the airspaces (and therefore 
BAL), after HDM dosing (Fig. 3D).    Co-localization of GFP was also observed with some 
CD16+ cells, thus we also detect Gli activity in a subset of phagocytic cells (Fig. 3E).  We 
did not detect GFP expression in CD31+ cells at 3wk, indicating that pulmonary endothelium 
does not express active Gli in AAD at this time-point (Fig. 3F).  These data indicate that lung 
epithelial cells, some eosinophils and phagocytes are all subject to Hh/Gli signaling during 
AAD.           
We also quantified cells expressing GliA by flow cytometry in whole lung homogenates and 
in bronchial alveolar lavage (BAL). Interestingly, at 3 weeks the majority of eosinophils in 
BAL expressed GFP (Fig. 4A) as did a lower but still substantial proportion of neutrophils 
(Fig. 4B).  GFP expression was sustained in these cells into the 5th week of allergen dosing 
(Fig. 4C). GFP expression was also observed in a proportion of lung eosinophils (Fig. 4D, E), 
in a minority of lung neutrophils and a subset of lung macrophages (Fig. 4F).  These data 
indicate that innate immune cells, in particular a significant subset of eosinophils, are capable 
of responding to Hh or other Gli-activating signals during allergen inhalation.  To our 
knowledge, this has not been previously reported. We noted a much higher frequency of 
GFP+ eosinophils in BAL and lung digests when we analyzed samples from our AAD 
experiments by flow cytometry (Fig. 4) compared to immunofluorescence (Fig. 3).  This may 
be due to enhanced sensitivity of cytometry or to cytometric gating strategies and lung 
cryosections, which are extensively washed during staining, may simply not mimic the 
cellular content of intact whole lung digests.  Alternatively, this may represent a real 
difference in Gli activation; BAL contains eosinophils that have egressed from pulmonary 
tissue, which may well have received Hh signals when passing through the epithelial barrier.  
Lung/BAL eosinophils are also functionally distinct during AAD, with inflammatory 
eosinophils located in BAL and peri-bronchial areas and regulatory eosinophils found largely 
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in lung parenchyma [23].  The function of eosinophils can thus be heavily influenced by their 
location in tissue presumably via responses to local microenvironmental signals; we propose 
that Shh/Gli signaling is one such local signal, active during allergic responses. 
Lung epithelium, endothelium and innate immune cells, particularly eosinophils, express key 
molecules of the Hh signaling pathway 
To confirm that lung tissue and innate immune cells express the machinery required for 
Hh/Gli signaling, we sorted epithelial and endothelial cells, eosinophils, neutrophils, 
macrophages and CD4+ T-cells from lung digests of WT mice and performed qPCR to assess 
gene expression.  In control mice, epithelial cells expressed Shh (as in [5]), Ihh, Hhip, Ptch, 
Smo and Gli1 indicating potential to both produce Hh ligand and receive Hh signals (Fig. 
5A).  Endothelial cells expressed negligible levels of Shh but did express Hh signaling 
machinery (Fig. 5A).  Upon HDM inhalation, epithelial cells expressed all of the genes as 
above.  Interestingly, compared to epithelial cells, endothelial cells expressed slightly higher 
levels of Hhip, Ptch, Smo and Gli1 (Fig. 5B).  This indicates that the Hh signaling capacity in 
the endothelial cells of the pulmonary vasculature may change from their baseline state 
following allergen exposure.     
The respiratory epithelium is an important physical barrier and ‘immune’ organ, increasingly 
linked to the initiation and maintenance of unwanted allergic immune responses.  House dust 
mite allergens including Derp1 protease disrupt epithelial tight junctions [24], permitting 
transepithelial passage of allergen and immune priming.  Derp1 also stimulates the release of 
pro-inflammatory cytokines from respiratory epithelium [25], which are important in 
subsequent immune skewing. We show for the first time that lung epithelia also expresses Hh 
signaling machinery during AAD, suggesting that auto/paracrine Hh signaling is possible in 
this compartment following allergen inhalation.  Embryogenic morphogens such as Shh are 
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re-expressed in adult lung to maintain epithelial and mesenchymal cell quiescence [22].  
Dysregulation of this signaling is strongly implicated in pulmonary fibrosis in mouse models 
[20] and man [26].  It is plausible that Shh signaling in epithelial cells may contribute to the 
long-term fibrotic airway remodeling seen in chronic asthma.  Hh signaling regulates the 
epithelial to mesenchymal transition (EMT) during lung development and branching 
morphogenesis.  Asthma has been proposed as a disorder of dysregulated EMT, although this 
is controversial.  Nevertheless, morphogenetic pathways appear to be good candidates for 
driving EMT during lung disease, including asthma (reviewed in [27]). 
Naïve (Fig. 5C) and allergen exposed (Fig. 5D) eosinophils expressed Ptch and Smo, Hh 
receptor and signal transduction molecules respectively, and Gli1 at higher levels than any of 
the other innate immune cells, and indeed higher than CD4+ T-cells.  Interestingly, naïve 
eosinophils also expressed Hh ligands, Shh and Dhh, and Hhip (Fig. 5C).  These cells are 
recruited to BAL (hundreds of thousands) and lung (millions) in abundance during the 
induction of AAD (Fig. S1C) and thus are likely to be a major source of Hh ligand. 
Surprisingly, following allergen treatment, Ihh expression was induced in eosinophils (Fig. 
5D).  There is little literature on this, although Ihh has a role in thymocyte development [28] 
and macrophage polarization [29].  It will be important to fully characterize this and the role 
of Hh signaling in other innate immune cells before Hh inhibitors are investigated as a 
potential therapy for Th2 mediated disease. Neutrophils and macrophages from HDM-
exposed mice expressed Hh signal transduction molecules Ptch and Smo, but at lower levels 
than eosinophils (Fig. 5D). As in baseline conditions (Fig. 5C), neutrophils retained the 
ability to express Hh ligands.  As neutrophil recruitment is impacted by repression of Gli-
dependent transcription in T-cells (Fig. 2C) and that neutrophils are Gli responsive (Fig. 4), it 
will be very interesting to examine the role of Hh/Gli signaling in neutrophilic/Th17 asthma.  
Macrophages expressed Shh and Ihh but not Dhh after HDM inhalation (Fig. 5D).  Shh/Gli 
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ligand expression and/or signaling has been previously reported in macrophages/monocytes 
[29-31]. There is evidence that macrophages upregulate both Shh and Ihh following exposure 
to schistosome antigens and that this can lead to M2 polarisation and a subsequent pro-
fibrotic environment in the liver [29].  It remains to be seen whether Hh signaling in lung 
during AAD favors M2 differentiation and pulmonary fibrosis or airway remodeling.   
HHIP is expressed in adult lung tissue including the lung epithelium (Fig. 5), pulmonary 
endothelium (Fig. 5) and eosinophils (Fig. 5).  Several genome-wide association studies 
(GWAS) have repeatedly identified SNPs at the HHIP locus, the endogenous inhibitor of 
Hedgehog ligands, to affect lung function [32-34] and to predispose to increased 
susceptibility to asthma [12].  Patients with COPD have decreased HHIP mRNA and protein 
expression [35]. Functionally, two of the associated SNPs have been shown to be within a 
HHIP enhancer region which interacts with the HHIP promotor, and both SNPs reduce 
promotor activity [35]. Altered HHIP levels may well lead to enhanced Shh signaling, and we 
speculate perhaps consequently similar corollaries as we have reported here. 
Shh activates Gli-dependent transcription via the canonical pathway - we have established 
that the components of the canonical hedgehog pathway are present in the lung tissue and 
immune cells. However we also acknowledge that Hh ligand can signal non–canonically and 
that Gli-dependent transcription can be triggered by non-Hh ligands, such as TGF beta [36].  
The crosstalk of these signaling pathways in AAD and asthma therefore warrants further 
investigation. 
Eosinophils, recruited to lung and BAL in high numbers in AAD, can respond to Hh signals 
by upregulating transcription of Il4 
Our data suggest that eosinophils, key cells in the Th2 response, are able to produce Hh 
ligands and respond to Hh signals.  To directly test the effect of Shh signaling to eosinophils, 
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we purified SiglecF+ cells from murine lung and spleen and cultured the cells in the presence 
or absence of recombinant mouse Shh.  As in CD4+ T-cells [5], Shh treatment triggered 
upregulation of Il4 in eosinophils (Fig. 5E).  This suggests that Hh ligands, produced by 
various lung cell types during AAD can further potentiate Th2 cytokine production.  This 
could explain why repression of Gli activity in T-cells only (Lck-Gli2R transgenic) did not 
significantly alter total IL-4 concentration in AAD lung tissue (Fig. 2C).  However, the Smo 
inhibitor cyclopamine promotes eosinophilic differentiation of leukemic myeloid cells [37], 
thus it is currently unclear what role Hh signaling plays in eosinophil differentiation and/or 
function.   
Our initial model proposing that Shh is released from lung epithelial cells following allergen 
inhalation therefore requires modification to include CD45+ innate leukocytes such as 
eosinophils and neutrophils (Fig. 6, white arrows).  The model should also be extended to 
reflect the Hh/Gli signaling potential of eosinophil, CD16+ and epithelial cell subsets (Fig. 6, 
black arrows), and the influence of Shh on Il4 transcription in eosinophils, potentially 
exacerbating the local Th2 response (Fig. 6, dashed arrow).  The full consequences of Gli 
activation in each of the cell types examined here are currently unknown.  In addition to its 
roles in maintaining quiescence and tissue homeostasis, postnatal re-expression of Shh in 
lung may therefore also have evolved as a beneficial Th2-potentiating mechanism to protect 
against lung parasites.  Of note, Shh production is increased in astrocytes of mice infected 
with Angiostrongylus cantonensis, the rat lungworm [38].  However, in allergy, excess Shh in 
lung tissue is potentially pathological as it may be exacerbating Th2-driven disease. This 
requires further investigation in order to fully characterize the role of Hh signaling in the 
allergic lung, which is clearly complex. Of further interest are Group 2 innate lymphoid cells 
(ILC2), which lack antigen receptors but are early producers of Th2 cytokines in immune 
responses.  These cells are particularly important in driving Th2 responses in the papain-
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induced AAD model [39].  Interestingly, ILC2 development is regulated by morphogeneic 
pathways NOTCH and Wnt/β-catenin (reviewed in [40]), thus it is important to establish 
whether there is a role for Hh/Gli signaling in the differentiation/function of this cell type.             
In summary, this study has uncovered a new role for Hh signaling in the cross-talk between 
pulmonary cells and infiltrating leukocytes during the induction of an allergic immune 
response.  Future work should determine the role of canonical and non-canonical Hh/Gli 
signaling in eosinophils, neutrophils and airway epithelia in the presence and absence of 
allergens.  The Hh/Gli signaling pathway is complex and subject to several regulatory and 
feedback mechanisms.  It will be very interesting to dissect the kinetics of Hh/Gli signaling in 
these cell types during AAD.  It is not currently clear in which cell type, if any, Hh signaling 
is absolutely required for AAD induction.  It may well be the case that Hh signaling is 
another pathway that contributes to, rather than controls, disease pathogenesis.    Together 
this information should uncover novel biological mechanisms and allow the rational design of 
potential modulators of Th2-driven lung disease.    
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Figure legends 
Figure 1: Lymphocytes respond to Hh signaling in vivo during AAD 
GFP-Gli reporter mice (GFP-Gli+, GFP+) and WT (GFP-Gli-, GFP-) littermates (n=3 per 
group) underwent repeated intranasal challenge with PBS or 25μg HDM allergen in 
PBS.   (A) Mean±SEM  cell number in BAL,  leukocytes in LN and lung digests (row across, 
all p-values n/s), in GFP-Gli+ groups (B, C) GFP status of CD4+ cells in LN, numbers on 
plots indicates %cells positive.  Mean±SEM  number of (D) GFP+ lymphocytes and (E) 
CD4+ cells in BAL and in (F, G) lung respectively.  *p≤0.05; **p≤0.005, compared to the 
control group at t=0 wks.  
Figure 2: Repression of Gli activation in T-cells lowers Th2 cell recruitment and neutrophilia 
in AAD  
C2 (Gli2R) and WT littermates (n=5 or 6 per group) underwent intranasal challenge with 
PBS or 25μg HDM allergen in PBS, receiving nine doses over three weeks.   Flow cytometric 
analysis of mean±SEM number of (A) CD4+T1ST2+ Th2 cells in lung digests, (B) in LN,  
(C) percentage of CD11bhiLy6G(IA8)+CD11c-SiglecF- neutrophils in live lung (grey bars) 
and BAL (white bars) leukocyte gates, and (D) number of eosinophils in BAL (top panel) and 
lung (lower panel).  (E) Periodic Acid Schiff (PAS) and hematoxylin staining of FFPE lung 
sections, *indicates highly cellular immune infiltrates, magnification x20, representative 
examples are shown (F) operator-blinded scoring of cellular infiltration and mucus 
production in PAS/hematoxylin sections: 0-1 = minimal, 1-2 = moderate, 2-3 = severe.  (G) 
ELISA analysis of cytokine concentration in whole lung homogenates.  *p≤0.05; **p≤0.005, 
ng = negligible.  
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Figure 3: GFP-Gli is expressed in epithelial cells and subsets of innate leukocytes 
(A) GFP expression in GFP-Gli- control and (B) in GFP-Gli+ lung cryosections, 
magnification x10.  Immunofluorescence of GFP-Gli+ lung cryosections after 3wk allergen 
inhalation following co-staining with anti- (C) E-cadherin, (D) SiglecF, (E) CD16 and (F) 
CD31.  (C-F) top panels, magnification x10; lower panels, magnification x100, scale bars are 
shown on last panels in each row.  Co-localization in red/green merged images can be seen as 
yellow or paler pink depending on the intensity of green fluorescence. 
Figure 4: Innate immune cells express can respond to Hh/Gli signals during AAD in vivo 
GFP-Gli reporter mice (n=3 in each group) underwent repeated intranasal challenge with 
25μg HDM allergen in PBS as described. Flow cytometry was used to analyze (A) 
eosinophils (B) neutrophils in BAL.  Representative flow profiles are shown at 3 weeks, 
numbers indicate % of eosinophils, bold numbers indicate % of live gate.  (C) Percentage and 
number per ml BAL of GFP+ eosinophils and neutrophils, (D) %GFP+ in lung CD4+ T-cell 
populations and number of GFP+ lung (E) eosinophils, (F) neutrophils and macrophages.  
*p≤0.05; **p≤0.005, compared to the control group at t=0 wks.    
 
Figure 5: Innate immune cells, particularly eosinophils, express key molecules of the Hh 
signaling pathway 
Lungs were harvested from (A, B) C57BL/6 (n=3 per group) or (C, D) Balb/c WT (n=2 per 
group) allergen naïve (A, C) or HDM-treated (B, D) mice and (A, B) lung epithelial and 
endothelial, or (C, D) resident lung eosinophils, neutrophils, macrophages and CD4+ T-cells 
were sorted by FACS as in Methods and subjected to gene expression analysis by qPCR.  
Expression of Shh, Hhip, Ptch, Smo, Gli1, Ihh and Dhh are expressed relative to Hprt in each 
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cell subset, data points represent individual mice.  (E) SiglecF+ cells were separated from 
WT mice (n=2 independent experiments) and cultured for 24h in the presence (+Shh) or 
absence (control) of 500ng/ml recombinant mouse Shh protein.  Expression of Il4 in the 
treated group was assessed by qPCR in triplicate, relative to the control samples.  
 Figure 6: Multiple cell types in lung produce and respond to Shh, potentiating Th2 responses 
as a consequence of allergen inhalation in AAD 
Our working model [5] has been updated to incorporate our new findings.  We propose that 
in addition to triggering allergic immune responses via CD4+ Th2 activation, HDM allergen 
also induces the release of Shh in lung (HDM action: grey arrows).  Shh is the primary Hh 
ligand secreted in the lung during AAD (Shh ligand, black circles) and that the source cells 
include epithelia, eosinophils and other CD45+ leukocytes (Shh release: white arrows).  T-
cells are able to respond to Shh, leading to Gli activation and upregulation of genes involved 
in Th2 skewing, leading to the potentiation of Th2 pathology and further inflammation/injury, 
potentially further increasing Shh expression.  Epithelial cells and some CD16+ cells express 
active Gli (black arrows), likely in response to Shh, but the outcome of the signal to these cell 
types is currently unknown.  Eosinophils also express activated Gli, and one consequence of 
this via Shh signaling is the upregulation of IL4, which may further drive Th2 activation and 
pathology.   
 






